HALO
NASDAQ · Biotechnology
Halozyme Therapeutics Inc
$103.63
-19.33 (-15.72%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
-79.7% upside
Low Target
$15.29
Average Target
$21.02
High Target
$24.22
Current Price
$103.63
Current
$103.63
$103.63
Target
$21.02
$21.02
$15.29
$21.02 avg
$24.22
Scenario Analysis
Bear Case
$15.29
-85.2%
Low target
Base Case
$21.02
-79.7%
Avg target
Bull Case
$24.22
+-76.6%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$134.00
-22.7% from high
52-Week Low
$61.23
+69.2% from low
50-Day SMA
$115.19
-10.0% vs SMA
200-Day SMA
$84.66
+22.4% vs SMA
RSI (14)
26.6
Oversold
Target vs 52W High
$21.02
-84.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |